A
Andros Pharmaceuticals Co Ltd
TPEX:6917
Andros Pharmaceuticals Co Ltd
TPEX:6917
Precio:
35,2
TWD
3,68%
Mercado cerrado
Capitalización de mercado:
NT$1,95 B
Agregar nota
Añadir objetivo
Captura tus ideas y establece un objetivo
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
Basado en
Margen de seguridad
0%
10%
20%
30%
40%
50%
Tu precio objetivo
Vinculado a
precio actual
· En zona de compra
Cargando
Nota vinculada
Elige la acción que deseas seguir con un precio objetivo
Vistos recientemente
|
A
|
Andros Pharmaceuticals Co Ltd
TPEX:6917
|
TW |
|
U
|
Union Auction PCL
SET:AUCT
|
TH |
|
Netcompany Group A/S
F:60N
|
DK |
|
C
|
Ciscom Corp
CNSX:CISC
|
CA |
|
Coforge Ltd
BSE:532541
|
IN |
|
Roctool SA
F:4CP
|
FR |
|
Communication Cable Systems Indonesia Tbk PT
IDX:CCSI
|
ID |
|
M
|
Molecule Holdings Inc
CNSX:MLCL
|
CA |
Valor intrínseco
No disponible para Andros Pharmaceuticals Co Ltd
No hay suficientes datos para calcular de forma fiable el valor intrínseco de Andros Pharmaceuticals Co Ltd.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Alternativas a Andros Pharmaceuticals Co Ltd
Análisis fundamental
Qué hace Andros Pharmaceuticals
Andros Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company. The company is headquartered in Zhubei, Hsinchu. The company went IPO on 2023-01-12. The products are focused on topical drugs and are developed with a focus on pain-related indications. The firm is mainly engaged in the authorization of product technology transfer, as well as the manufacture and sales of niche generic drugs and high-end skin care products.
- Sede central
- Taiwán TW
- Fecha de salida a bolsa
- 12 ene., 2023
Finanzas
Eficiencia
Cascada de ganancias
Andros Pharmaceuticals Co Ltd
Andros Pharmaceuticals Co Ltd
